Reading Time: 3 minutesTUDCA-ALS is a European Consortium (funded by the European Commission under the Horizon 2020 grant) involving top researchers from seven countries across Europe (see Figure
Category: News
Reading Time: 3 minutesResearchers from University College London led by Dr Pietro Fratta and Dr John Thornton found that muscle imaging can help distinguish Amyotrophic Lateral Sclerosis (ALS)
Reading Time: 4 minutesRecently published results from the open-label Lighthouse trial investigating safety of the drug Triumeq in people with MND revealed the treatment was safe and ready
Reading Time: 5 minutesDespite the winter chill, there is a warm fuzzy feeling today with the news of a paper published in the journal ‘Brain’ by an MND
Reading Time: 7 minutesIn November 2018 the Home Office released a draft Guideline scope for Cannabis-based products for medicinal use in which they announced that specialist doctors (like
Reading Time: 5 minutesThere has recently been a flood of news stories on the outcomes of the Australian Phase 1 clinical trial investigating Copper ATSM (CuATSM) which is
Reading Time: 2 minutesOn Friday 5 May in America, the FDA, the organisation that approves drugs, announced that they’d granted a licence for the drug known as a
Reading Time: 3 minutesYesterday the Reta Lila Weston Trust announced that they will be funding Dr Nikhil Sharma and colleagues at the Leonard Wolfson Experimental Neurology Centre (LWENC)
Reading Time: 3 minutesOver 100 talks were given at this month’s International Symposium on ALS/MND in Dublin. There were also over 450 posters of research being presented too.
Reading Time: 4 minutesAs well as all the networking, debate and new information being shared, the International Symposium on ALS/MND is also a time to celebrate achievements by